Losartan Potassium Active Pharmaceutical Ingredient (API) Market Anticipated to Grow at 6.5% CAGR Through 2029: Industry Report

 Crafted for informed planning, this report explores the forces reshaping the losartan potassium active pharmaceutical ingredient (api) market and what they mean for business leaders.





What Is The Projected Market Size & Growth Rate Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

The losartan potassium active pharmaceutical ingredient (api) market size has grown strongly in recent years. It will grow from $1.75 billion in 2024 to $1.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to the growing adoption of antihypertensive drugs, the increasing incidence of lifestyle-related disorders, the rise in awareness about cardiovascular health, the increasing healthcare expenditure globally, and the rising demand for affordable generic medications.



The losartan potassium active pharmaceutical ingredient (api) market size is expected to see strong growth in the next few years. It will grow to $2.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to an expanding patient pool with chronic illnesses, a growing focus on preventive cardiovascular care, increasing penetration of healthcare services in emerging markets, advancements in drug formulation technologies, and rising government initiatives for generic drug promotion. Major trends in the forecast period include advancement in manufacturing processes, advanced drug delivery systems, development of pediatric-friendly formulations, innovation in packaging for extended shelf life, and development of combination therapies with losartan.



Get your free sample today:

Losartan Potassium API Market Report 2025, Share & Outlook 2034 Sample



What Is The Crucial Factor Driving The Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

The growing prevalence of hypertension is expected to propel the growth of the losartan potassium active pharmaceutical ingredient (API) market going forward. Hypertension is a condition marked by persistently high blood pressure, which can raise the likelihood of heart disease, stroke, and other severe health complications. The growing incidence of hypertension is linked to diets rich in salt and processed foods, which lead to fluid retention and increased heart strain. Losartan potassium helps control hypertension by blocking angiotensin II, a hormone that narrows blood vessels. It helps relax and widen the vessels, lowering blood pressure and easing the heart's workload. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, there were 131,454 deaths primarily linked to high blood pressure in 2022, an increase from 124,508 deaths in 2021. Therefore, the growing prevalence of hypertension is driving the growth of the losartan potassium active pharmaceutical ingredient (API) market.



Segment Covered In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report

The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –



1) By Product Type: Tablet, Capsule, Other Product Types

2) By Production Method: Synthetic Route, Biotechnological Process, Continuous Flow Production

3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications

5) By End-User: Hospitals, Clinics, Home Care Settings, Pharmaceutical Companies



Subsegments:

1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets

2) By Capsule: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules

3) By Other Product Types: Injectable Formulations, Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates



Key Trends Driving Growth In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market

Major companies operating in the losartan potassium active pharmaceutical ingredient (API) market are focusing on developing innovative products and getting approvals, such as losartan potassium oral suspension, to enhance patient compliance and expand therapeutic applications. Losartan potassium oral suspension is a liquid form of medication losartan potassium, intended for individuals who struggle with swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) approval for Arbli. Arbli is a ready-to-use liquid formulation for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. It offers precise dosing without compounding and is available in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.



Key Player In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market

Major companies operating in the losartan potassium active pharmaceutical ingredient (API) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP



View the full losartan potassium active pharmaceutical ingredient (api) market report here:

Losartan Potassium API Market Report 2025, Share & Outlook 2034



Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market - Regional Insights:

North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.



Contact Us:



The Business Research Company



Market Research Reports



Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267



Email: info@tbrc.info





Follow Us On:



LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Future of the Antifungals Market: Insights, Developments, and Strategic Overview

Image
 Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the antifungals industry. Antifungals Market Valuation Forecast: What Will The Market Be Worth By 2025? The antifungals market size has grown strongly in recent years. It will grow from $27.16 billion in 2024 to $29.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education. The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, ...
Read more

Polybutylene Terephthalate (PBT) Market Analysis 2025 – Supporting High-Stakes Corporate Planning

Image
 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Polybutylene Terephthalate (PBT) industry. What is the projected value of the polybutylene terephthalate (pbt) market by 2029? The polybutylene terephthalate (PBT) market size has grown strongly in recent years. It will grow from $2.5 billion in 2024 to $2.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to adoption in new industries, global economic conditions, electrical vehicle adoption, consumer goods and textile applications, advancements in material properties. The polybutylene terephthalate (PBT) market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued focus on...
Read more

Zero Trust Security Market Report 2025 – Insights for Decision Makers and Market Strategists

Image
 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the zero trust security industry by 2029? The zero trust security market size has grown rapidly in recent years. It will grow from $38.45 billion in 2024 to $45.05 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to cyber threat landscape, legacy security challenges, digital transformation, remote workforce trend, data privacy concerns. The zero trust security market size is expected to see exponential growth in the next few years. It will grow to $99.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to threat intelligence integration, user-centric security approach, data volume growth, business co...
Read more